1. Home
  2. NTLA vs AHG Comparison

NTLA vs AHG Comparison

Compare NTLA & AHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intellia Therapeutics Inc.

NTLA

Intellia Therapeutics Inc.

HOLD

Current Price

$12.33

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

AHG

Akso Health Group ADS

HOLD

Current Price

$2.19

Market Cap

1.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTLA
AHG
Founded
2014
2013
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
2016
2017

Fundamental Metrics

Financial Performance
Metric
NTLA
AHG
Price
$12.33
$2.19
Analyst Decision
Buy
Analyst Count
23
0
Target Price
$20.02
N/A
AVG Volume (30 Days)
4.4M
13.9K
Earning Date
05-07-2026
08-14-2025
Dividend Yield
N/A
N/A
EPS Growth
27.43
N/A
EPS
N/A
N/A
Revenue
$67,671,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$62.75
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.92
N/A
52 Week Low
$6.83
$1.08
52 Week High
$28.24
$2.50

Technical Indicators

Market Signals
Indicator
NTLA
AHG
Relative Strength Index (RSI) 40.61 51.82
Support Level $11.19 $2.15
Resistance Level $14.71 $2.46
Average True Range (ATR) 1.18 0.19
MACD -0.27 -0.01
Stochastic Oscillator 11.03 54.24

Price Performance

Historical Comparison
NTLA
AHG

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

About AHG Akso Health Group ADS

Akso Health Group is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.

Share on Social Networks: